Loading

JNJ — JOHNSON & JOHNSON · PureTicker

Dashboard Screener Smart Money Ask

More▾

Chart read News S&P 500 Pricing Methodology

☰✕

Dashboard Screener Smart Money Ask

Chart read News S&P 500 Pricing Methodology

JNJ

JOHNSON & JOHNSONC5015-min delayed · EOD close

266.34▲ +0.29% upas of 2026-09-14mkt cap $641B

Pharmaceutical Preparations · SIC 2834 · CIK 0000200406

Key Stats Financials Fair Value Quality Technicals Peers Smart Money Ratings News

Chart read News S&P 500 Pricing Methodology Terms Privacy

Research and education only. Not investment advice, not a broker or registered adviser, and no trade execution. Data from SEC EDGAR and Yahoo Finance.

Market cap

$641B

P/E

39.8

Net margin

16.2%

ROE

19.7%

Revenue

$99.3B

latest annual

Net income

$16.1B

latest annual

Shares out

2.4B

Free cash flow

$20.6B

52-week range

Current: 266.34

▲

Low

170.34

High

278.43

Quality score

50/100

C

Growth46

Business quality70

Financial health30

Valuation54

Computed from filed fundamentals against fixed reference bands. Not a recommendation, and not a peer percentile.